Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IM Cannabis Corp (NQ: IMCC )

2.830 +0.060 (+2.17%)
Streaming Delayed Price Updated: 2:07 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,649
Open 2.770
Bid (Size) 2.790 (1)
Ask (Size) 2.900 (1)
Prev. Close 2.770
Today's Range 2.770 - 2.918
52wk Range 1.134 - 8.100
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3
International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue... 
Via Benzinga
Topics Cannabis Economy
Exposures Cannabis Supply Chain
A Peek at IM Cannabis's Future Earnings
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
+38.68%
+38.68%
1 Month
+34.12%
+34.12%
3 Month
-0.18%
-0.18%
6 Month
-24.65%
-24.65%
1 Year
+12.30%
+12.30%

More News

Read More
Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About
Via Benzinga
Topics Cannabis
Exposures Cannabis
Earnings Scheduled For November 14, 2024
Via Benzinga
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know
Via Benzinga
Topics Cannabis
Exposures Cannabis
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?
Via Benzinga
Topics Cannabis
Exposures Cannabis
IMCC Stock Earnings: IM Cannabis Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
Via Benzinga
Topics Cannabis
Exposures Cannabis
European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Shares Surge 586% After 6:1 Consolidation: What Investors Need To Know
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know
Via Benzinga
Topics Cannabis
Exposures Cannabis
Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany
Via Benzinga
Topics Cannabis
Exposures Cannabis
Weed Industry Celebrates Biden's Rescheduling Move: 'Most Monumental Cannabis Reform In Half A Century'
Via Benzinga
Topics Cannabis
Exposures Cannabis
Weed Stocks Rally After Biden Makes Marijuana Reclassification Announcement
Via Benzinga
Topics Cannabis
Exposures Cannabis
Flora Growth Goes Back To Net Loss In Q1, Positive About 'Landmark Reform' In The US, Focuses On Europe
Via Benzinga
IMCC Stock Earnings: IM Cannabis Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue
Via Benzinga
Topics Cannabis
Exposures Cannabis
Breaking on The Street Stocks To Watch Now! CTMX, PRSO, IMCC, KAVL, VTAK
Via AB Newswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
What's Going On With IM Cannabis Stock?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Is CVRx (CVRX) Stock Down 32% Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.